학술논문

184TiP FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Subject
*NON-small-cell lung carcinoma
*FIBROBLAST growth factor receptors
Language
ISSN
0923-7534